Introduction: Omega-3 polyunsaturated fatty acids (omega-3 PUFAs) are not synthesized by
the human body; they must be derived from dietary sources and they have been known to be …

Background Despite omega-3 polyunsaturated fatty acids (PUFA) supplementation in
depressed patients have been suggested to improve depressive symptomatology, previous …

Research has established that docosahexaenoic acid (DHA), a long-chain omega-3
polyunsaturated fatty acid (PUFA), plays a fundamental role in brain structure and function …

A growing literature suggests the association of low tissue levels and/or dietary intake of n-
polyunsaturated fatty acids (PUFA) with depressive illnesses. Animal studies show that low …

Patients with depression have been extensively reported to be associated with the
abnormality of omega-3 polyunsaturated fatty acids (PUFAs), including significantly low …

Omega-3 polyunsaturated fatty acid (PUFA) supplementation has been proposed as
(adjuvant) treatment for major depressive disorder (MDD). In the present meta-analysis, we …

Depression is a common, recurrent, and debilitating illness that has become more prevalent
over the past 100 years. This report reviews the etiology and pathophysiology of depression …

Introduction Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are recommended as an
integrative treatment for major depressive disorder (MDD). In 2019, the International Society …

Background Major depressive disorder (MDD) is highly debilitating, difficult to treat, has a
high rate of recurrence, and negatively impacts the individual and society as a whole. One …

Objective The aim of this study is to systematically review the efficacy of omega-3
polyunsaturated fatty acid (n-3 PUFA) supplements in reducing depressive symptoms …